Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Nordea Bank AB (publ) in connection with a bond issue of up to 1500 MSEK
Mandate

Vinge has advised Nordea Bank AB (publ) in connection with a bond issue of up to 1500 MSEK

April 18, 2017 Banking and Finance

Vinge has advised Nordea Bank AB (publ) in connection with a bond issue of up to 1500 MSEK, issued by SBB i Norden AB (publ) on 6 April 2017.

Nordea Bank AB (publ) acted as issuing agent. The bonds have a tenor of three years and a floating interest rate of three-months Stibor plus 6 per cent.

The proceeds from the bond issue will be issued for general corporate purposes, which include financing of property acquisitions. SBB i Norden AB (publ) will apply for the bonds to be listed on Nasdaq Stockholm.

Vinges team consisted of Mikael Ståhl, Josefine Larsson, André Isacson and Lionardo Ojeda.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026